Scott Buzby is an Online Content Editor at Healio. He focuses on themes related to medicine and healthcare, including medical specialties, alternative medicine, and health and wellness, while also addressing social issues such as AI and the impact of the coronavirus. Scott's work has been featured in various publications, highlighting his expertise in diagnostics and the perspectives of clinicians and medical practitioners.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Not enough data
Scott's articles focus heavily on scientific and healthcare topics, particularly cardiology and cardiovascular disease. Given his heavy reliance on data and press releases, he would likely be most responsive to pitches from researchers, medical professionals or industry experts who can provide factual insights backed by research findings or newsworthy data.
Potential outreach could include offering exclusive access to newly released studies, providing expert commentary on the implications of emerging medical research in the field of cardiology and related areas, as well as highlighting innovative approaches to healthcare that align with Scott’s coverage themes.
As Scott does not have a specific geographic focus but covers international health-related news stories extensively, sources from anywhere in the world may find relevance in reaching out for potential collaboration.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Richard Smith, Scott Buzby
Improved screening for elevated lipoprotein(a) levels among all adults may improve CVD risk assessment and outcomes, especially with multiple Lp(a)-lowering therapies currently in the research pipeline, a speaker reported.
By: Scott Buzby, Richard Smith, Katie Kalvaitis
Key takeaways: A speaker highlighted key advances in the treatment of hypertension in 2024.
By: Mark Drazner, Scott Buzby, Richard Smith
The American College of Cardiology recently issued an expert consensus document outlining a novel staging system and decision pathway for the diagnosis, treatment and longitudinal follow-up of patients with myocarditis.
By: Scott Buzby, Richard Smith
The health benefits of time-restricted eating go beyond weight loss and may be most prominent in patients already with cardiometabolic syndrome at baseline, a speaker reported.
By: Scott Buzby, Richard Smith
A daily polypill was estimated to be cost-effective for primary CVD prevention among U.S. adults living in historically underserved communities with limited health care access and low income, researchers reported.
By: Richard Smith, Scott Buzby
Maintaining healthful behaviors may be key to improving the trajectory of heart health from early adolescence into adulthood, according to study findings published in JAMA Cardiology
By: Scott Buzby
High genetically predicted LDL was inversely associated with risk for incident diabetes, whereas the opposite trend was observed for CAD risk, researchers reported.“Individual genetic studies have yielded informative observations between LDL-C and type 2 diabetes,” Akshaya Ravi, an undergraduate researcher at the Broad Institute of MIT and Harvard, and colleagues wrote.
By: Richard Smith, Scott Buzby
Recent changes to a heart transplant allocation policy improved waitlist outcomes for children born with heart defects and adults with cardiomyopathy, but
By: Richard Smith, Scott Buzby
Key takeaways: A speaker highlighted key advances in lipid treatment in 2024. Topics included triglyceride and lipoprotein(a) management as well as another setback to the “HDL hypothesis.”
By: Richard Smith, Scott Buzby
After the COVID-19 pandemic, the incidence rate of postural orthostatic tachycardia syndrome increased significantly, according to new data published in the European Heart Journal – Quality of Care and Clinical Outcomes
(833) 317-6278 
